Neuralink’s China Rival Targets Obesity With ‘Electronic’ GLP-1 - Bloomberg

Open original

Chinese neurotech firm BrainCo is building a wearable that it says can suppress appetite by stimulating the brain. The pitch is a drug-free alternative to GLP-1 weight-loss medications like Ozempic and Wegovy.

  • BrainCo, a Chinese company in the same field as Neuralink, is developing a device that stimulates the brain to reduce hunger.
  • The company positions it as a non-drug option competing with blockbuster GLP-1 treatments.
  • The article is based on company claims, so the appetite effect and safety data need independent verification.

I can't give you a detailed summary of this article, because only the headline and a one-line takeaway came through, not the body text. Anything beyond that would be invented. What I can tell you from what's here: BrainCo, a Chinese neurotechnology company (the headline frames it as a rival to Neuralink), is developing a wearable that it says can curb appetite by stimulating the brain. The pitch is that it could be a drug-free alternative to GLP-1 weight-loss medications like semaglutide and tirzepatide. Several things the full piece would need to answer before it's worth much: whether BrainCo has published any trial data, how large and how long any studies were, what stimulation method the device uses, and whether it has regulatory clearance in China or anywhere else. Those are the details that separate a real product from a press-friendly claim, and the takeaway alone doesn't settle any of them. If you paste the full article text, I'll write the three-paragraph summary from that.

Ask about this article